What type of study is this?

This is a In Vitro Study study.

December 4, 2025BiomedicinesOpen Access

Antibody-Mediated In Vitro Activation and Expansion of Blood Donor-Derived Natural Killer Cells with Transient Anti-Tumor Efficacy

View Full Paper

Ask AI

Bookmark

Enhanced tumor suppression achieved through in vitro activation of natural killer cells.
Natural killer cells showed significantly improved cytotoxicity against tumor cells in vitro and in vivo.
Cytokine treatments included IL-2 and interleukin-15, emphasizing their role in cell activation.
Results indicate that the approach may advance allogeneic NK cell-based immunotherapy for cancer patients.

No takes yet. Share an insight, caveat, or question.

Cytotoxicity improvements in natural killer cells via IL-2 and interleukin-15 suggest potential for cancer therapies.

Luo et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark